High-throughput decoding of drug targets and drug resistance mechanisms in African trypanosomes

Parasitology

Volumn 141, Issue 1, 2014, Pages 77-82

  Horn, David ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Leishmania; RIT seq; RNA interference; Trypanosoma brucei; Trypanosoma cruzi

Indexed keywords

ANTIPARASITIC AGENT; ANTITRYPANOSOMAL AGENT; PROTOZOAL PROTEIN;

ARTICLE; DRUG RESISTANCE; DRUG TARGETING; DRUG UPTAKE; ESSENTIAL GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOME; HIGH THROUGHPUT SCREENING; NONHUMAN; PARASITE VIABILITY; PRIORITY JOURNAL; RNA INTERFERENCE; TRYPANOSOMA BRUCEI; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG EFFECTS; GENE LIBRARY; GENETICS; HUMAN; METABOLISM; PARASITOLOGY; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; DRUG RESISTANCE; GENE LIBRARY; GENOME, PROTOZOAN; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PROTOZOAN PROTEINS; RNA INTERFERENCE; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 84891891016     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182013000243     Document Type: Article

References (32)

1. Alsford, S., Turner, D. J., Obado, S. O., Sanchez-Flores, A., Glover, L., Berriman, M., Hertz-Fowler, C. and Horn, D. (2011). High-Throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome. Genome Research 21, 915-924
2. Alsford, S., Eckert, S., Baker, N., Glover, L., Sanchez-Flores, A., Leung, K. F., Turner, D. J., Field, M. C., Berriman, M. and Horn, D. (2012). High-Throughput decoding of antitrypanosomal drug efficacy and resistance. Nature 482, 232-236 doi: 10.1038/nature10771
3. Bacchi, C. J., Nathan, H. C., Hutner, S. H., Mccann, P. P. and Sjoerdsma, A. (1980). Polyamine metabolism: A potential therapeutic target in trypanosomes. Science 210, 332-334
4. Baker, N., Alsford, S. and Horn, D. (2011). Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6. Molecular and Biochemical Parasitology 176, 55-57
5. Baker, N., Glover, L., Munday, J. C., Aguinaga Andres, D., Barrett, M. P., De Koning, H. P. and Horn, D. (2012). Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes. Proceedings of the National Academy of Sciences, USA 109, 10996-11001 doi: 1202885109 [pii] 10.1073/pnas.1202885109
6. Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., Renauld, H., Bartholomeu, D. C., Lennard, N. J., Caler, E., Hamlin, N. E., Haas, B., Bohme, U., Hannick, L., Aslett, M. A., Shallom, J., Marcello, L., Hou, L., Wickstead, B., Alsmark, U. C., Arrowsmith, C., Atkin, R. J., Barron, A. J., Bringaud, F., Brooks, K., Carrington, M., Cherevach, I., Chillingworth, T. J., Churcher, C., Clark, L. N., Corton, C. H., Cronin, A., Davies, R. M., Doggett, J., Djikeng, A., Feldblyum, T., Field, M. C., Fraser, A., Goodhead, I., Hance, Z., Harper, D., Harris, B. R., Hauser, H., Hostetler, J., Ivens, A., Jagels, K., Johnson, D., Johnson, J., Jones, K., Kerhornou, A. X., Koo, H., Larke, N., Landfear, S., Larkin, C., Leech, V., Line, A., Lord, A., Macleod, A., Mooney, P. J., Moule, S., Martin, D. M., Morgan, G.W., Mungall, K., Norbertczak, H., Ormond, D., Pai, G., Peacock, C. S., Peterson, J., Quail, M. A., Rabbinowitsch, E., Rajandream, M. A., Reitter, C., Salzberg, S. L., Sanders, M., Schobel, S., Sharp, S., Simmonds, M., Simpson, A. J., Tallon, L., Turner, C. M., Tait, A., Tivey, A. R., Van Aken, S., Walker, D., Wanless, D., Wang, S., White, B., White, O., Whitehead, S., Woodward, J. (2005). The genome of the African trypanosome Trypanosoma brucei. Science 309, 416-422
7. Brun, R., Blum, J., Chappuis, F. and Burri, C. (2010). Human African trypanosomiasis. Lancet 375, 148-159
8. Ehrlich, P. (1913). Address in pathology, on chemotherapy: Delivered before the Seventeenth International Congress of Medicine. British Medical Journal 2, 353-359
9. El-Sayed, N. M., Myler, P. J., Bartholomeu, D. C., Nilsson, D., Aggarwal, G., Tran, A. N., Ghedin, E., Worthey, E. A., Delcher, A. L., Blandin, G., Westenberger, S. J., Caler, E., Cerqueira, G. C., Branche, C., Haas, B., Anupama, A., Arner, E., Aslund, L., Attipoe, P., Bontempi, E., Bringaud, F., Burton, P., Cadag, E., Campbell, D. A., Carrington, M., Crabtree, J., Darban, H., Da Silveira, J. F., De Jong, P., Edwards, K., Englund, P. T., Fazelina, G., Feldblyum, T., Ferella, M., Frasch, A. C., Gull, K., Horn, D., Hou, L., Huang, Y., Kindlund, E., Klingbeil, M., Kluge, S., Koo, H., Lacerda, D., Levin, M. J., Lorenzi, H., Louie, T., Machado, C. R., Mcculloch, R., Mckenna, A., Mizuno, Y., Mottram, J. C., Nelson, S., Ochaya, S., Osoegawa, K., Pai, G., Parsons, M., Pentony, M., Pettersson, U., Pop, M., Ramirez, J. L., Rinta, J., Robertson, L., Salzberg, S. L., Sanchez, D. O., Seyler, A., Sharma, R., Shetty, J., Simpson, A. J., Sisk, E., Tammi, M. T., Tarleton, R., Teixeira, S., Van Aken, S., Vogt, C., Ward, P. N., Wickstead, B., Wortman, J., White, O., Fraser, C. M., Stuart, K.D. and Andersson, B. (2005). The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309, 409-415 doi: 10.1126/science.1112631
10. Frearson, J. A., Brand, S., Mcelroy, S. P., Cleghorn, L. A., Smid, O., Stojanovski, L., Price, H. P., Guther, M. L., Torrie, L. S., Robinson, D. A., Hallyburton, I., Mpamhanga, C. P., Brannigan, J. A., Wilkinson, A. J., Hodgkinson, M., Hui, R., Qiu, W., Raimi, O. G., Van Aalten, D. M., Brenk, R., Gilbert, I. H., Read, K. D., Fairlamb, A. H., Ferguson, M. A., Smith, D. F. and Wyatt, P. G. (2010). N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature 464, 728-732 doi: Nature08893 [pii] 10.1038/nature08893
11. Hall, B. S., Bot, C. and Wilkinson, S. R. (2011). Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites. Journal of Biological Chemistry 286, 13088-13095 doi: M111.230847 [pii] 10.1074/jbc.M111.230847
12. Hopkins, A. L. (2008). Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology 4, 682-690 doi: Nchembio.118 [pii] 10.1038/nchembio.118
13. Horn, D. and McCulloch, R. (2010). Molecular mechanisms underlying the control of antigenic variation in African trypanosomes. Current Opinion in Microbiology 13, 700-705 doi: S1369-5274(10)00123-2 [pii] 10.1016/j. mib.2010.08.009
14. Ivens, A. C., Peacock, C. S., Worthey, E. A., Murphy, L., Aggarwal, G., Berriman, M., Sisk, E., Rajandream, M. A., Adlem, E., Aert, R., Anupama, A., Apostolou, Z., Attipoe, P., Bason, N., Bauser, C., Beck, A., Beverley, S. M., Bianchettin, G., Borzym, K., Bothe, G., Bruschi, C. V., Collins, M., Cadag, E., Ciarloni, L., Clayton, C., Coulson, R. M., Cronin, A., Cruz, A. K., Davies, R. M., De Gaudenzi, J., Dobson, D. E., Duesterhoeft, A., Fazelina, G., Fosker, N., Frasch, A. C., Fraser, A., Fuchs, M., Gabel, C., Goble, A., Goffeau, A., Harris, D., Hertz-Fowler, C., Hilbert, H., Horn, D., Huang, Y., Klages, S., Knights, A., Kube, M., Larke, N., Litvin, L., Lord, A., Louie, T., Marra, M., Masuy, D., Matthews, K., Michaeli, S., Mottram, J. C., Muller-Auer, S., Munden, H., Nelson, S., Norbertczak, H., Oliver, K., O'Neil, S., Pentony, M., Pohl, T. M., Price, C., Purnelle, B., Quail, M. A., Rabbinowitsch, E., Reinhardt, R., Rieger, M., Rinta, J., Robben, J., Robertson, L., Ruiz, J. C., Rutter, S., Saunders, D., Schafer, M., Schein, J., Schwartz, D. C., Seeger, K. (2005). The genome of the kinetoplastid parasite, Leishmania major. Science 309, 436-442 doi: 10.1126/science.1112680
15. Jacobs, R. T., Nare, B., Wring, S. A., Orr, M. D., Chen, D., Sligar, J. M., Jenks, M. X., Noe, R. A., Bowling, T. S., Mercer, L. T., Rewerts, C., Gaukel, E., Owens, J., Parham, R., Randolph, R., Beaudet, B., Bacchi, C. J., Yarlett, N., Plattner, J. J., Freund, Y., Ding, C., Akama, T., Zhang, Y. K., Brun, R., Kaiser, M., Scandale, I. and Don, R. (2011). SCYX-7158, an orally-Active benzoxaborole for the treatment of stage 2 human African trypanosomiasis. PLoS Neglected Tropical Diseases 5, e1151 doi: 10.1371/journal.pntd.0001151 PNTD-D-10-00094 [pii].
16. Kaiser, M., Bray, M. A., Cal, M., Bourdin Trunz, B., Torreele, E. and Brun, R. (2011). Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness. Antimicrobial Agents and Chemotherapy 55, 5602-5608 doi: AAC.00246-11 [pii] 10.1128/AAC.00246-11
17. MacGregor, P., Szoor, B., Savill, N. J. and Matthews, K. R. (2012). Trypanosomal immune evasion, chronicity and transmission: An elegant balancing act. Nature Reviews Microbiology 10, 431-438 doi: Nrmicro2779 [pii] 10.1038/nrmicro2779
18. Magarinos, M. P., Carmona, S. J., Crowther, G. J., Ralph, S. A., Roos, D. S., Shanmugam, D., Van Voorhis, W. C. and Aguero, F. (2012). TDR targets: A chemogenomics resource for neglected diseases. Nucleic Acids Research 40, D1118-D1127 doi: Gkr1053 [pii] 10.1093/nar/ gkr1053
19. Maser, P., Sutterlin, C., Kralli, A. and Kaminsky, R. (1999). A nucleoside transporter from Trypanosoma brucei involved in drug resistance. Science 285, 242-244
20. Morris, J. C., Wang, Z., Drew, M. E. and Englund, P. T. (2002). Glycolysis modulates trypanosome glycoprotein expression as revealed by an RNAi library. EMBO Journal 21, 4429-4438
21. Ngo, H., Tschudi, C., Gull, K. and Ullu, E. (1998). Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proceedings of the National Academy of Sciences, USA 95, 14687-14692
22. Pepin, J. and Milord, F. (1994). The treatment of human African trypanosomiasis. Advances in Parasitology 33, 1-47
23. Priotto, G., Kasparian, S., Mutombo, W., Ngouama, D., Ghorashian, S., Arnold, U., Ghabri, S., Baudin, E., Buard, V., Kazadi-Kyanza, S., Ilunga, M., Mutangala, W., Pohlig, G., Schmid, C., Karunakara, U., Torreele, E. and Kande, V. (2009). Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: A multicentre, randomised, phase III, non-inferiority trial. Lancet 374, 56-64 doi: S0140-6736(09) 61117-X [pii] 10.1016/S0140-6736(09)61117-X.
24. Roy Chowdhury, A., Bakshi, R., Wang, J., Yildirir, G., Liu, B., Pappas-Brown, V., Tolun, G., Griffith, J. D., Shapiro, T. A., Jensen, R. E. and Englund, P. T. (2010). The killing of African trypanosomes by ethidium bromide. PLoS Pathogenesis 6, e1001226 doi: 10.1371/journal.ppat.1001226
25. Schumann Burkard, G., Jutzi, P. and Roditi, I. (2011). Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters. Molecular and Biochemical Parasitology 175, 91-94
26. Shapiro, T. A. and Englund, P. T. (1990). Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs. Proceedings of the National Academy of Sciences, USA 87, 950-954
27. Stewart, M. L., Krishna, S., Burchmore, R. J., Brun, R., De Koning, H. P., Boykin, D.W., Tidwell, R. R., Hall, J. E. and Barrett, M. P. (2005). Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test. Lancet 366, 486-487. doi: S0140-6736(05)66793-1 [pii] 10.1016/S0140-6736(05)66793-1
28. Vanhollebeke, B. and Pays, E. (2010). The trypanolytic factor of human serum: Many ways to enter the parasite, a single way to kill. Molecular Microbiology 76, 806-814 doi: MMI7156 [pii] 10.1111/j.1365-2958.2010.07156.x.
29. Vincent, I. M., Creek, D., Watson, D. G., Kamleh,M. A., Woods, D. J., Wong, P. E., Burchmore, R. J. and Barrett, M. P. (2010). A molecular mechanism for eflornithine resistance in African trypanosomes. PLoS Pathogenesis 6, e1001204
30. Wilkinson, S. R., Taylor, M. C., Horn, D., Kelly, J. M. and Cheeseman, I. (2008). A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proceedings of the National Academy of Sciences, USA 105, 5022-5027
31. Wilson, W. D., Tanious, F. A., Mathis, A., Tevis, D., Hall, J. E. and Boykin, D.W. (2008). Antiparasitic compounds that target DNA. Biochimie 90, 999-1014 doi: S0300-9084(08)00051-5 [pii] 10.1016/j. biochi.2008.02.017
32. Wyllie, S., Patterson, S. and Fairlamb, A. H. (2012). Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro-drug activation. Antimicrobial Agents and Chemotherapy doi: AAC.01788-12 [pii] 10.1128/AAC.01788-12